| A Standardized Nursing Intervention Protocol for HCT Patients (NCT00951626) | City of Hope Medical Center | 2005-09-01 |
| S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease (NCT00898066) | SWOG Cancer Research Network | 2005-09-01 |
| S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma (NCT00109928) | SWOG Cancer Research Network | 2005-09-01 |
| Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants (NCT00606437) | Duke University | 2005-09-01 |
| Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma (NCT00101010) | M.D. Anderson Cancer Center | 2005-09-01 |
| Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma (NCT00345865) | Masonic Cancer Center, University of Minnesota | 2005-08-24 |
| AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders (NCT00547196) | City of Hope Medical Center | 2005-08-16 |
| Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) (NCT00361140) | H. Lee Moffitt Cancer Center and Research Institute | 2005-08-01 |
| Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer (NCT00255749) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger (NCT00290498) | M.D. Anderson Cancer Center | 2005-08-01 |
| Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment (NCT00436618) | Mayo Clinic | 2005-08-01 |
| Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors (NCT00112619) | Pediatric Brain Tumor Consortium | 2005-08-01 |
| Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage (NCT00248443) | Assistance Publique - Hôpitaux de Paris | 2005-08-01 |
| Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases (NCT00309842) | Masonic Cancer Center, University of Minnesota | 2005-07-28 |
| VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders (NCT00304005) | Vion Pharmaceuticals | 2005-07-01 |
| Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer (NCT00349024) | Children's Cancer and Leukaemia Group | 2005-07-01 |
| S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma (NCT00121186) | SWOG Cancer Research Network | 2005-07-01 |
| Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas (NCT00955786) | Cylene Pharmaceuticals | 2005-07-01 |
| A Phase II Study of Umbilical Cord Blood Transplantation (NCT00676806) | Tufts Medical Center | 2005-07-01 |
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer (NCT00546377) | Memorial Sloan Kettering Cancer Center | 2005-07-01 |
| Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL) (NCT00243087) | Boehringer Ingelheim | 2005-07-01 |
| Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma (NCT00217503) | National Cancer Institute (NCI) | 2005-07-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia (NCT00133991) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-07-01 |
| Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant (NCT00321932) | University of Minnesota | 2005-07-01 |
| Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma (NCT00863369) | City of Hope Medical Center | 2005-06-29 |
| Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease (NCT00129753) | M.D. Anderson Cancer Center | 2005-06-22 |
| Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer (NCT00611351) | University of Nebraska | 2005-06-07 |
| Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer (NCT00295880) | Masonic Cancer Center, University of Minnesota | 2005-06-01 |
| Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma (NCT00234026) | Swiss Cancer Institute | 2005-06-01 |
| A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) (NCT00127140) | Merck Sharp & Dohme LLC | 2005-06-01 |
| Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant (NCT00305682) | Masonic Cancer Center, University of Minnesota | 2005-06-01 |
| 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology (NCT00207298) | British Columbia Cancer Agency | 2005-06-01 |
| Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma (NCT00117975) | Alliance for Clinical Trials in Oncology | 2005-06-01 |
| Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan (NCT00496873) | M.D. Anderson Cancer Center | 2005-06-01 |
| BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma (NCT00126646) | MedImmune LLC | 2005-06-01 |
| Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00245037) | OHSU Knight Cancer Institute | 2005-06-01 |
| Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma (NCT00398554) | Christine Mauz-Körholz | 2005-06-01 |
| Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases (NCT00317785) | Fred Hutchinson Cancer Center | 2005-05-01 |
| A Phase I Trial of ZIO-101 in Hematologic Cancers (NCT00592046) | Alaunos Therapeutics | 2005-05-01 |
| Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (NCT00541034) | Memorial Sloan Kettering Cancer Center | 2005-05-01 |
| Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer (NCT00818961) | Northside Hospital, Inc. | 2005-05-01 |
| Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) (NCT00117598) | Pfizer | 2005-05-01 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain (NCT00666211) | Vanderbilt-Ingram Cancer Center | 2005-05-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia (NCT00295997) | University of California, San Francisco | 2005-05-01 |
| Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath (NCT00578942) | David Rizzieri, MD | 2005-05-01 |
| Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT (NCT00586690) | David Rizzieri, MD | 2005-05-01 |
| Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome (NCT00466921) | Northwestern University | 2005-04-19 |
| Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma (NCT00040911) | Children's Oncology Group | 2005-04-01 |
| Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT (NCT00586703) | David Rizzieri, MD | 2005-04-01 |
| Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT00262860) | University of Rochester | 2005-04-01 |
| Metabolic Syndrome in Childhood Cancer Survivors (NCT00920738) | University of Minnesota | 2005-04-01 |
| Healthy Exercise for Lymphoma Patients (HELP) (NCT00111865) | Lance Armstrong Foundation | 2005-04-01 |
| Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma (NCT00166439) | Academic and Community Cancer Research United | 2005-03-01 |
| Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma (NCT00093704) | Jonsson Comprehensive Cancer Center | 2005-03-01 |
| Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies (NCT00990717) | University Health Network, Toronto | 2005-03-01 |
| Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients (NCT00186940) | St. Jude Children's Research Hospital | 2005-03-01 |
| Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer (NCT01147991) | Cancer Research UK | 2005-03-01 |
| Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma (NCT00238433) | OHSU Knight Cancer Institute | 2005-03-01 |
| Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma (NCT00109798) | The Methodist Hospital Research Institute | 2005-03-01 |
| Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies (NCT00472056) | M.D. Anderson Cancer Center | 2005-03-01 |
| Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00104975) | Yale University | 2005-02-01 |
| Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia (NCT00105313) | MedImmune LLC | 2005-02-01 |
| Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer (NCT00104923) | California Cancer Consortium | 2005-02-01 |
| Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma (NCT00590941) | Washington University School of Medicine | 2005-02-01 |
| Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) (NCT00109031) | Swedish Orphan Biovitrum | 2005-01-01 |
| Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma (NCT00278161) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-01-01 |
| Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment (NCT00544284) | City of Hope Medical Center | 2005-01-01 |
| A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma (NCT00266370) | National Health Research Institutes, Taiwan | 2005-01-01 |
| Non-Myeloablative Allogeneic Stem Cell Transplantation (NCT00525876) | M.D. Anderson Cancer Center | 2005-01-01 |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer (NCT00357500) | Dana-Farber Cancer Institute | 2005-01-01 |
| Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 (NCT00896662) | Vanderbilt-Ingram Cancer Center | 2005-01-01 |
| Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993) | Case Comprehensive Cancer Center | 2005-01-01 |
| Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00138164) | Jonsson Comprehensive Cancer Center | 2004-12-01 |
| Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma (NCT00091091) | Children's Oncology Group | 2004-12-01 |
| Psychosocial Impact of Cancer-Related Female Infertility (NCT00386217) | M.D. Anderson Cancer Center | 2004-12-01 |
| Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma (NCT00884286) | PharmaMar | 2004-12-01 |
| Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma (NCT00110006) | Case Comprehensive Cancer Center | 2004-12-01 |
| Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma (NCT00427765) | M.D. Anderson Cancer Center | 2004-12-01 |
| Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma (NCT00082836) | Memorial Sloan Kettering Cancer Center | 2004-12-01 |
| Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia (NCT00060346) | Eastern Cooperative Oncology Group | 2004-10-05 |
| Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma (NCT00098774) | Alliance for Clinical Trials in Oncology | 2004-10-01 |
| Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00134004) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-10-01 |
| Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors (NCT00365768) | Columbia University | 2004-10-01 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma (NCT00072488) | American College of Radiology Imaging Network | 2004-10-01 |
| Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial (NCT00897767) | Eastern Cooperative Oncology Group | 2004-09-21 |
| Phase 2 Study of Bexxar in Relapsed/Refractory DLCL (NCT00490009) | Susan Knox | 2004-09-01 |
| Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides (NCT00103246) | Case Comprehensive Cancer Center | 2004-09-01 |
| Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma (NCT00275106) | Children's Cancer and Leukaemia Group | 2004-09-01 |
| Alemtuzumab and Pentostatin In T-cell Neoplasms (NCT00453193) | M.D. Anderson Cancer Center | 2004-09-01 |
| Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma (NCT00112931) | University College, London | 2004-09-01 |
| Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00301951) | University of California, San Francisco | 2004-09-01 |
| Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma (NCT00104819) | Favrille | 2004-09-01 |
| Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma (NCT00093769) | Jonsson Comprehensive Cancer Center | 2004-08-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00096096) | Fred Hutchinson Cancer Center | 2004-08-01 |
| Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma (NCT00258336) | Favrille | 2004-08-01 |
| Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma (NCT00307710) | M.D. Anderson Cancer Center | 2004-08-01 |
| Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma (NCT00214370) | University of Wisconsin, Madison | 2004-07-01 |
| Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00087425) | National Institute on Aging (NIA) | 2004-07-01 |
| Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma (NCT00101101) | H. Lee Moffitt Cancer Center and Research Institute | 2004-07-01 |